health
Recent-infection testing could reduce TB vaccine-trial enrolment needs
A statistical model estimated that testing for recent tuberculosis infection could reduce the median number of people needed for a vaccine trial by 4.2- to 6-fold compared with long-lasting IGRA positivity under favourable conditions. The estimates are preprint model results, and the authors say candidate tests still need to be characterised.